A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
|Articles|August 10, 2011
El aborto y la ley - Colombia
Advertisement
Advertisement
Related to this article
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA removes boxed warnings from 3 more menopausal hormone therapy products
2
Choosing Among Hormonal and Nonhormonal VMS Therapies in Menopause
3
Chrisandra Shufelt, MD, on cardiovascular prevention at menopause
4
FDA grants accelerated approval to DNA immunotherapy for adult recurrent respiratory papillomatosis
5